Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Can Ultrasound-detected Subclinical Inflammation Explain Patient's Global Assessment of Disease Activity in Psoriatic Arthritis Considered in Remission ?

NCT03396679 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.

NCT NCT03396679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03396679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Can Ultrasound-detected Subclinical Inflammation Explain Patient's Global Assessment of Disease Activity in Psoriatic Arthritis Considered in Remission ?
Lead sponsor
University Hospital, Montpellier
Phase
Observational
Overall status
Completed
Start date
November 2, 2017
Completion date
June 29, 2018
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

psa patients fulfilling caspar criteria in remission